Lack of Correlation of the Serum 25(OH) Vitamin D Levels with the Glycated Hemoglobin A1c and the Lipid Profile in Type 2 Diabetes Patients on Oral Antidiabetic Drugs – Preliminary Data

1 . Al - Shoume r, K. A. et al. Does insulin resistance in type 2 diabetes alter vitamin D status? -Prim. Care Diabetes, 7, 2013, № 4, 283-7. 10.1016/j.pcd.2013.04.00823685025Search in Google Scholar

2 . Bakalov, D., M. Boyanov, A. Tsakova, et al. Prevalence of deficiency and insufficiency of vitamin D in patients with type 2 diabetes mellitus on oral antidiabetic drugs. - Endocrinologia, 18, 2013, № 1, 19-26. (article in Bulgarian). Search in Google Scholar

3 . Borissova, А. М. et al. Frequency of vitamin D deficiency and insufficiency in the Bulgarian population ≥ 20-80 years. - Endocrinologia, 17, 2012, № 3, 122-134 (article in Bulgarian). Search in Google Scholar

4 . Borissova, A-M., Ts. Tankova, G. Kirilov, et al. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. - Int. J. Clin. Pract., 57, 2003, № 4, 258-261. Search in Google Scholar

5 . Calle, C., M. Begoña et M. García-Arencibia. Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats. - BMC Molecular Biology, 9, 2008, 65. 10.1186/1471-2199-9-65253334718638371Search in Google Scholar

6 . Chacko , S. A., Y. Song, J. E. Manson, et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. - Am. J. Clin. Nutr., 94, 2011, № 1, 209-217. 10.3945/ajcn.110.010272312752421613558Search in Google Scholar

7 . Ganji, V. et al. Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006. - Am. J. Clin. Nutr., 94, 2011, №1, 225-233. 10.3945/ajcn.111.01351621613551Search in Google Scholar

8 . George , P. S., E. R. Pearson et M. D. Witham. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. - Diabet. Med., 29, 2012, № 8, e142-50. 10.1111/j.1464-5491.2012.03672.x22486204Search in Google Scholar

9 . Gradinaru, D. et al. Vitamin D Status and Oxidative Stress Markers in Elderly with Impaired Fasting Glucose and Type 2 Diabetes Mellitus. - Aging Clin. Exp. Res., 24, 2012, № 6, 595-602. Search in Google Scholar

10 . Husemoen , L. L. et al. Serum 25(OH)D and type 2 diabetes association in a general population: a prospective study. - Diabetes Care, 35, 2012, № 8, 1695-1700. 10.2337/dc11-1309340226522688545Search in Google Scholar

11 . Hutchinson , M. S. et al. Serum 25-hydroxyvitamin D levels in subjects with reduced glucose tolerance and type 2 diabetes - the Tromsø OGTT-study. - Int. J. Vitam. Nutr. Res., 81, 2011, № 5, 317-327. 10.1024/0300-9831/a00007922419202Search in Google Scholar

12 . Jorde, R. et al. High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. - Eur. J. Clin. Nutr., 64, 2010, № 12, 1457-1464. 10.1038/ejcn.2010.17620823896Search in Google Scholar

13 . Jorde, R. et G. Grimnes. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. - Prog. Lipid Res., 50, 2011, № 4, 303-312. 10.1016/j.plipres.2011.05.00121640757Search in Google Scholar

14 . Kampmann , U. et al. Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency - a double-blind, randomized, placebo-controlled trial. - Metabolism, 63, 2014, № 9, 1115-1124. 10.1016/j.metabol.2014.06.00825044176Search in Google Scholar

15 . Luo, C. et al. Hypovitaminosis D in Chinese type 2 diabetes: Lack of impact on clinical metabolic status and biomarkers of cellular inflammation. - Diab. Vasc. Dis. Res., 6, 2009, № 3, 194-199. 10.1177/147916410933797420368211Search in Google Scholar

16 . Mc Gill , A-T. et al. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. - Nutr. J., 7, 2008, 4. 10.1186/1475-2891-7-4226573818226257Search in Google Scholar

17 . Menon, R. K. et al. The effects of vitamin D2 or D3 supplementation on glycaemic control and related metabolic parameters in people at risk of type 2 diabetes: protocol of a randomised doubleblind placebo-controlled trial. - BMC Public Health, 13, 2013, 999. 10.1186/1471-2458-13-999381900324152375Search in Google Scholar

18 . Ministry of Health. Guideline for the diagnosis, prevention and treatment of vitamin D deficiency and insufficiency. Bulgarian Societies of Rheumatology, Endocrinology, Pediatrics and Clinical Laboratory, 2013 (in Bulgarian). Search in Google Scholar

19 . Nasri, H. et al. Impact of oral vitamin D (cholecalciferol) replacement therapy on blood pressure in type 2 diabetes patients; a randomized, double-blind, placebo controlled clinical trial. - J. Nephropathol., 3, 2014, № 1, 29-33. Search in Google Scholar

20 . Palomer, X. et al. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. - Diab. Obes. Metab., 10, 2008, № 3, 185-197. 10.1111/j.1463-1326.2007.00710.x18269634Search in Google Scholar

21 . Pittas , A.G., J. Lau, F.B. Hu et B. Dawson-Hughes. The role of vitamin D and calcium in Type 2 Diabetes. A systematic review and meta-analysis. - J. Clin. Endocrinol. Metab., 92, 2007, № 6, 2017-2029. 10.1210/jc.2007-0298208523417389701Search in Google Scholar

22 . Ponda, M. P. et al. Vitamin D may not improve lipid levels: A serial clinical laboratory data study. - Circulation, 126, 2012, № 3, 270-277. 10.1161/CIRCULATIONAHA.111.077875371362522718799Search in Google Scholar

23 . Toxqui , L. et al. Changes in blood pressure and lipid levels in young women consuming a vitamin D-fortified skimmed milk: A randomised controlled trial. - Nutrients, 5, 2013, № 12, 4966-4977. 10.3390/nu5124966387590924317556Search in Google Scholar

24 . Yilmaz , H. et al. Is vitamin D status a predictor of glycaemic regulation and cardiac complication in type 2 diabetes mellitus patients? - Diab. Metab. Syndr., 6, 2012, № 1, 28-31.10.1016/j.dsx.2012.05.00723014251Search in Google Scholar

25. Yu , J. R. et al. Serum vitamin D status and its relationship to metabolic parameters in patients with type 2 diabetes mellitus. - Chonnam Med. J., 48, 2012, № 2, 108-115. 26 . Zhao , Y. et al. Association of vitamin D receptor gene polymorphisms with metabolic syndrome: a case-control design of population-based cross-sectional study in North China. - Lipids Health Disease, 13, 2014, 129. Search in Google Scholar